Modern clinical oncology emphasises the value of biomarkers and their utility in diagnosing, monitoring and treating what is recognised as an increasingly complex disease.

Clinical cancer research relies on diverse techniques, methodologies and matrices to test for markers key in identifying the right patient for the right drug, as well as demonstrating drug biological activity.

Quintiles’ global laboratories offer comprehensive tissue and fluid-based testing for protein biomarkers, and robust methods for DNA / ribonucleic acid (RNA) analysis to analyse tumours at the nucleic acid level.